Related Experiment Video
Updated: Aug 12, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
[Nosocomial fungal infections, analysis of 149 cases]
Zheng-Yin Liu1, Rui-Yuan Sheng, Xu-Li Li
1Department of Infectious Disease, Peking Union Medical College Hospital, Beijing 100730, China.
Objective:
To investigate the manifestation, diagnosis, antifungal therapy and outcome of nosocomial fungal infections.
Methods:
The clinical data of 149 patients with nosocomial fungal infections admitted in the PUMC hospital from Dec. 1981 to Nov. 2001, 67 males and 82 females with an average age of 52.32 years, including the manifestation, diagnosis, treatment and outcome, were reviewed retrospectively.
Results:
134 out of the 149 patients suffered from deep mycoses. All cases had underlying conditions, including primary pulmonary diseases (n = 29), rheumatic disease (n = 20), hematological disease such as leukemia or lymphoma (n = 18), HIV infection/AIDS (n = 13), major surgery (n = 10), and intracerebral hemorrhage or cerebral infarction (n = 24). The predisposing factors or risk factors for deep mycoses included use of high dose broad-spectrum antibiotics over a long period (n = 37), steroids/cytotoxic chemotherapy (n = 29), immunosuppressant (n = 17), chemotherapy (n = 10), intravenous lines and incubation (n = 36), and tracheotomy or endotracheal intubation (n = 12). The infectious sites were lung, meninges, cerebral parenchyma, blood, etc. in the order of prevalence. Depending on infectious site and type of fungus, the clinical manifestations included fever (63.76%), respiratory symptom such as cough (37.58%), leucocytosis (39.6%), chest X-ray images (24.49%) etc. CNS fungal infection included meningitis, brain abscess, and granuloma. Meningitis due to Cryptococcus resembled that due to Mycobacterium tuberculosis. The main pathogenic fungal species were Candida albicans, C. tropicalis, C. parapsilosis, C. neoformans, and Aspergillus species. Amphotericin B, fluconazole, and flucytosine were used alone or in combination. The overall mortality rate was 29.53% (44/149). Out of the 149 patients 67 were cured, 29 made improvement. The incidence of fungal infection remarkably increased recently with 75 cases appearing in the past 5 years (50.34%).
Conclusion:
The incidence of fungal infection is increasing recently which is correlated with use of high dose broad-spectrum antibiotics over a long period, high dose steroids/cytotoxic chemotherapy, immunosuppressant, chemotherapy, and improvement of examination skills, etc. The main pathogens are still Candida albicans and non-albicans Candida species. Early diagnosis is very important.
Insights
Nosocomial fungal infections are increasing, often linked to broad-spectrum antibiotics and chemotherapy. Early diagnosis and treatment are crucial for improving outcomes in these complex cases.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hospital Epidemiology
Context:
- Nosocomial fungal infections (NFIs) pose a significant challenge in healthcare settings.
- A retrospective analysis of 149 patients with NFIs was conducted at PUMC hospital from 1981 to 2001.
- The study examines the clinical characteristics, diagnostic approaches, therapeutic interventions, and outcomes of these infections.
Purpose:
- To investigate the clinical manifestations, diagnostic methods, antifungal therapies, and patient outcomes associated with nosocomial fungal infections.
- To identify trends in the incidence of NFIs over a 20-year period.
- To highlight the importance of early diagnosis in managing fungal infections.
Summary:
- Deep mycoses were prevalent in 134 of 149 patients, with underlying conditions including pulmonary diseases, hematological disorders, and HIV/AIDS.
- Common predisposing factors included prolonged broad-spectrum antibiotic use, chemotherapy, immunosuppressants, and invasive devices.
- Candida species and Cryptococcus neoformans were primary pathogens; mortality rate was 29.53%, with a notable increase in incidence in recent years.
Impact:
- The findings underscore a recent rise in fungal infections, correlating with increased use of antibiotics, chemotherapy, and immunosuppressants.
- Highlights the continued importance of Candida albicans and non-albicans Candida species as key pathogens.
- Emphasizes the critical need for prompt diagnosis and effective antifungal strategies to mitigate morbidity and mortality.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

